During the past decade, Universitätsklinikum Münster conducted 238 clinical trials. In the 10-year time frame, 238 clinical trials started and 85 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 107 clinical trials started and 61 clinical trials were completed. i.e. 57% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Münster" #1 sponsor was "University Hospital Muenster" with 31 trials, followed by "Boehringer Ingelheim" with 20 trials sponsored, "Pfizer" with 20 trials sponsored, "Janssen Research & Development, LLC" with 16 trials sponsored and "Eli Lilly and Company" with 16 trials sponsored. Other sponsors include 259 different institutions and companies that sponsored additional 173 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Münster" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "German Research Foundation" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator and "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include 206 different institutions and companies that were collaborators in the rest 174 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Münster" are "Psoriasis" (11 trials), "Acute Myeloid Leukemia" (10 trials), "Atopic Dermatitis" (9 trials), "Heart Failure" (9 trials) and "Atrial Fibrillation" (8 trials). Many other conditions were trialed in "Universitätsklinikum Münster" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Münster" are "Drug" (240 trials), "Device" (48 trials), "Biological" (37 trials), "Other" (29 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (61 trials), "Prednisone" (8 trials), "Cytarabine" (7 trials), "Carboplatin" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Münster" are 338 trials for "All" genders, 15 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsklinikum Münster". 1 are not yet recruiting, 85 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 168 completed trials in Universitätsklinikum Münster, undefined suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Münster, 22 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 32 trials that are defined as “Not Applicable".

Universitätsklinikum Münster has several departments that took part in Clinical trials: "Universitätsklinikum Münster; Klinik und Poliklinik für Neurologie" - 23 trials, "Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie" - 6 trials, "Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie" - 5 trials, "Universitäts-Kinderklinik, Päd. Hämatologie und Onkologie" - 6 trials, "Universitätsklinikum Münster, Klinik für Kardiologie I, Koronare Herzkrankheit, Herzinsuffizienz und Angiologie" - 2 trials, "Universitatsklinikum Munster, Transplant Hepatology" - 2 trials, "Dept. of Anesthesiology, Intensive Care and Pain Medicine, UKM" - 2 trials